Suppr超能文献

肾脏在健康和疾病中的水转运。

Renal water transport in health and disease.

机构信息

Department of Cell Physiology and Metabolism, University of Geneva, 1 Rue Michel Servet, CH-1211, Geneva 4, Switzerland.

Service of Nephrology, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland.

出版信息

Pflugers Arch. 2022 Aug;474(8):841-852. doi: 10.1007/s00424-022-02712-9. Epub 2022 Jun 9.

Abstract

Saving body water by optimal reabsorption of water filtered by the kidney leading to excretion of urine with concentrations of solutes largely above that of plasma allowed vertebrate species to leave the aquatic environment to live on solid ground. Filtered water is reabsorbed for 70% and 20% by proximal tubules and thin descending limbs of Henle, respectively. These two nephron segments express the water channel aquaporin-1 located along both apical and basolateral membranes. In the proximal tubule, the paracellular pathway accounts for at least 30% of water reabsorption, and the tight-junction core protein claudin-2 plays a key role in this permeability. The ascending limb of Henle and the distal convoluted tubule are impermeant to water and are responsible for urine dilution. The water balance is adjusted along the collecting system, i.e. connecting tubule and the collecting duct, under the control of arginine-vasopressin (AVP). AVP is synthesized by the hypothalamus and released in response to an increase in extracellular osmolality or stimulation of baroreceptors by decreased blood pressure. In response to AVP, aquaporin-2 water channels stored in subapical intracellular vesicles are translocated to the apical plasma membrane and raise the water permeability of the collecting system. The basolateral step of water reabsorption is mediated by aquaporin-3 and -4, which are constitutively expressed. Drugs targeting water transport include classical diuretics, which primarily inhibit sodium transport; the new class of SGLT2 inhibitors, which promotes osmotic diuresis and the non-peptidic antagonists of the V2 receptor, which are pure aquaretic drugs. Disturbed water balance includes diabetes insipidus and hyponatremias. Diabetes insipidus is characterized by polyuria and polydipsia. It is either related to a deficit in AVP secretion called central diabetes insipidus that can be treated by AVP analogs or to a peripheral defect in AVP response called nephrogenic diabetes insipidus. Diabetes insipidus can be either of genetic origin or acquired. Hyponatremia is a common disorder most often related to free water excess relying on overstimulated or inappropriate AVP secretion. The assessment of blood volume is key for the diagnosis and treatment of hyponatremia, which can be classified as hypo-, eu-, or hypervolemic.

摘要

通过肾脏最佳重吸收过滤的水分,从而将尿液中的溶质浓度大大高于血浆,这使得脊椎动物能够离开水生环境,在陆地上生存。过滤后的水分分别被近端小管和亨利氏细降支回吸收 70%和 20%。这两个肾单位部分表达了位于顶端和基底外侧膜的水通道 Aquaporin-1。在近端小管中,细胞旁途径至少占水重吸收的 30%,紧密连接核心蛋白 Claudin-2 在这种通透性中起着关键作用。亨利氏细升支和远曲小管对水是不可渗透的,负责尿液稀释。水平衡沿着集合系统进行调节,即连接小管和集合管,受精氨酸加压素 (AVP) 的控制。AVP 由下丘脑合成,并响应细胞外渗透压的增加或血压降低刺激的压力感受器而释放。响应 AVP,储存在亚顶点细胞内囊泡中的 Aquaporin-2 水通道被转运到顶端质膜,并提高集合系统的水通透性。水重吸收的基底外侧步骤由组成型表达的 Aquaporin-3 和 -4 介导。靶向水转运的药物包括主要抑制钠转运的经典利尿剂;新型 SGLT2 抑制剂,促进渗透利尿;以及 V2 受体的非肽拮抗剂,它们是纯 aquaretic 药物。水平衡紊乱包括尿崩症和低钠血症。尿崩症的特征是多尿和多饮。它要么与称为中枢性尿崩症的 AVP 分泌不足有关,可通过 AVP 类似物治疗,要么与 AVP 反应的外周缺陷有关,称为肾性尿崩症。尿崩症可以是遗传性的,也可以是获得性的。低钠血症是一种常见的疾病,最常与过度刺激或不适当的 AVP 分泌导致的自由水过多有关。对血容量的评估是诊断和治疗低钠血症的关键,低钠血症可分为低、等、高血容量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验